Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Multicenter, Randomized, Double-masked, Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®

NCT00274261 is registered in ClinicalTrials.gov with Premier Research as lead sponsor.

NCT NCT00274261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00274261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Multicenter, Randomized, Double-masked, Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®
Lead sponsor
Premier Research
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2004
Completion date
September 30, 2008
Enrollment
1,565 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy